Status:
COMPLETED
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
Lead Sponsor:
University of Aarhus
Conditions:
Metabolism
Insulin Resistance
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
This study will investigate the non-growth-hormone-dependent metabolic effects of the hormone Ghrelin in growth hormone deficient subjects by examining the insulin tolerance as well as signal proteins...
Detailed Description
Ghrelin is a relatively 'new' hormone that is produced in the stomach and to a lesser extend in the hypothalamus of the brain. The actions of ghrelin are diverse and includes stimulation of the appeti...
Eligibility Criteria
Inclusion
- males with hypopituitarism in regard to growth hormone and ACTH in stabile treatment regime
- age 18-65
- BMI 20-35
Exclusion
- abuse of alcohol
- malign disease
- medication other than that expected for hypopituitarism
- known disease other than hypopituitarism
- participation in isotope investigations the last 6 months
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2015
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01209416
Start Date
June 1 2012
End Date
October 1 2015
Last Update
October 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Aarhus
Aarhus, Denmark, 8000